SciDEX — MMSE

Understanding Entity Pages

This page aggregates everything SciDEX knows about MMSE: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

Outgoing (9)

Target	Relation	Type	Str
DIABETES	regulates	disease	0.60
TH	associated_with	gene	0.50
APP	associated_with	gene	0.50
CLU	associated_with	gene	0.50
CR1	associated_with	gene	0.50
ROS	associated_with	phenotype	0.50
CSF	associated_with	phenotype	0.45
IL6	associated_with	gene	0.45
TAU	associated_with	protein	0.45

Incoming (28)

Source	Relation	Type	Str
TAU	stabilizes	protein	0.60
DASATINIB	associated_with	drug	0.50
ENTORHINAL CORTEX	associated_with	brain_region	0.50
CORTEX	associated_with	brain_region	0.50
ASTROCYTE	associated_with	cell_type	0.50
NEURON	associated_with	cell_type	0.50
ALZHEIMER'S DISEASE	associated_with	disease	0.50
ALZHEIMER	associated_with	disease	0.50
MICROGLIAL ACTIVATION	associated_with	phenotype	0.50
COGNITIVE DECLINE	associated_with	phenotype	0.50
OXIDATIVE STRESS	associated_with	phenotype	0.50
SYNAPTIC LOSS	associated_with	phenotype	0.50
HIPPOCAMPUS	associated_with	brain_region	0.50
SENESCENCE	associated_with	phenotype	0.50
ASTROCYTES	associated_with	cell_type	0.50
QUERCETIN	associated_with	drug	0.50
MICROGLIA	associated_with	cell_type	0.50
NEUROINFLAMMATION	associated_with	phenotype	0.50
INFLAMMATION	associated_with	phenotype	0.50
AGING	associated_with	phenotype	0.50
DIABETES	associated_with	disease	0.50
IL10	associated_with	gene	0.45
IL18	associated_with	gene	0.45
NEURODEGENERATION	associated_with	phenotype	0.45
CYTOKINES	associated_with	phenotype	0.45
AMYLOID	associated_with	protein	0.45
DONANEMAB	associated_with	drug	0.45
DEMENTIA	associated_with	disease	0.45

MMSE

Understanding Entity Pages

Wiki Pages (21)

Microbiome-Metabolic-Inflammation Triad in AD: Experimental Protocol

Personalized Treatment Plan — Atypical Parkinsonism (CBS/PSP)

CBS/PSP Supplements Guide

Device Therapies Comparison for CBS/PSP

Section 148: Advanced Nutritional Biochemistry in CBS/PSP

Alzheimer's Disease

Outgoing (9)

Incoming (28)

Targeting Hypotheses (0)

Mentioning Analyses (0)

Related Papers (0)

MMSE

Understanding Entity Pages

Wiki Pages (21)

Microbiome-Metabolic-Inflammation Triad in AD: Experimental Protocol

Personalized Treatment Plan — Atypical Parkinsonism (CBS/PSP)

CBS/PSP Supplements Guide

Device Therapies Comparison for CBS/PSP

Section 148: Advanced Nutritional Biochemistry in CBS/PSP

Alzheimer's Disease

Circadian Rhythm in Neurodegeneration

TREM2 Microglial Signaling Pathway in Neurodegeneration

DIAN-TU-001 Trial (NCT01760005)

omega-3-fatty-acids-neurodegeneration

AI and Machine Learning in Neurodegeneration

Melatonin for Tauopathy: Comprehensive Evidence Synthesis

Vascular Cognitive Impairment (VCI)

Sulforaphane and Nrf2 Activation for Neuroprotection

Lithium for PSP/CBS — Phase 2 Trial

CSF Neurofilament Light Chain (NfL) in Neurodegeneration

dimethyl-fumarate-nrf2-ad-nct06850597

Infectious Triggers in Alzheimer's Disease

Section 152: Advanced Robotics and Assistive Devices in CBS/PSP

A Phase 3, Randomised, Double-blinded, Placebo-controlled Study to Evaluate the Efficacy, Tolerability, and Safety of Combined Metabolic Activator Supplementation in Subjects Diagnosed With Alzheimer's Disease

Copper Dyshomeostasis in Neurodegeneration

Outgoing (9)

Incoming (28)

Targeting Hypotheses (0)

Mentioning Analyses (0)

Related Papers (0)